DEVODIL

This brand name is authorized in Cyprus, Malta, Singapore.

Active ingredients

The drug DEVODIL contains one active pharmaceutical ingredient (API):

1	Sulpiride UNII 7MNE9M8287 - SULPIRIDE
	Sulpiride is a member of the group of substituted benzamides, which are structurally distinct from the phenothiazines, butyrophenones and thioxanthenes. One of the characteristics of sulpiride is its bimodal activity, as it has both antidepressant and neuroleptic properties. Schizophrenia characterised by a lack of social contact can benefit strikingly.
	Read more about Sulpiride

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DEVODIL Tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AL01	Sulpiride	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AL Benzamides
Discover more medicines within N05AL01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
MT	Medicines Authority	AA084/06901, AA084/06902
SG	Health Sciences Authority	01143P, 09937P